Participants
PD
Eligible participants were healthy males and females aged between 18 and 50 years, with a body weight of 35–150 kg and a body mass index (BMI) of 18–32 kg/mThe safety population included all randomized participants who received at least one dose of study intervention (analyzed based on treatment received). The PK population included all randomized participants who received at least one dose of study treatment, and for whom at least one post‐randomization PK sample was obtained, analyzed, and was measurable. The PD population included all randomized participants who received at least one dose of study treatment, and for whom at least one PD sample was obtained, analyzed, and was measurable.